Direkt zum Inhalt
Merck
  • Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Bioorganic & medicinal chemistry (2002-01-30)
Paul E Murray, Virginia A McNally, Stacey D Lockyer, Kaye J Williams, Ian J Stratford, Mohammed Jaffar, Sally Freeman
ZUSAMMENFASSUNG

A series of water soluble N(1)- and C(6)-substituted uracil pyridinium compounds were prepared as potential inhibitors of thymidine phosphorylase (TP). The C(6)-uracil substituted derivatives were the most active. 1-[(5-Chloro-2,4-dihydroxypyrimidin-6-yl)methyl]pyridinium chloride, was identified as the best inhibitor being 5-fold more potent than the known inhibitor, 6-amino-5-bromouracil.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
6-(Chlormethyl)uracil, 98%